Your session is about to expire
← Back to Search
Non-invasive Fat Reduction
The ZELTIQ System for Obesity (CSI Trial)
N/A
Waitlist Available
Research Sponsored by Zeltiq Aesthetics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up final post-treatment visit
Awards & highlights
CSI Trial Summary
This trial is testing a new, non-invasive fat reduction treatment to see if it is safe and effective.
Eligible Conditions
- Obesity
CSI Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ final post treatment visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~final post treatment visit
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Effectiveness endpoint gauged by reduction in fat layer thickness
Safety endpoint in relation to adverse events
Secondary outcome measures
Photo review
Subject survey
CSI Trial Design
1Treatment groups
Experimental Treatment
Group I: Fat ReductionExperimental Treatment1 Intervention
The treatments are designed to see if the fat can be reduced in the flanks with a new applicator design.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
The ZELTIQ System
2019
N/A
~220
Find a Location
Who is running the clinical trial?
Zeltiq AestheticsLead Sponsor
40 Previous Clinical Trials
1,529 Total Patients Enrolled
Kerrie Jiang, NPStudy DirectorZeltiq Aesthetics
9 Previous Clinical Trials
411 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger